-
1دورية أكاديمية
المؤلفون: Beth Russell, Katharina Beyer, Ailbhe Lawlor, Monique J. Roobol, Lionne D.F. Venderbos, Sebastiaan Remmers, Erik Briers, Sara J. MacLennan, Steven MacLennan, Muhammad Imran Omar, Mieke Van Hemelrijck, Emma Smith, James N'Dow, Karin Plass, Maria Ribal, Nicolas Mottet, Robert Shepherd, Tom Abbott, Ken Mastris, Lisa Moris, Michael Lardas, Thomas Van den Broeck, Peter-Paul Willemse, Nicola Fossati, Karl Pang, Riccardo Campi, Isabella Greco, Mauro Gacci, Sergio Serni, Anders Bjartell, Ragnar Lonnerbro, Alberto Briganti, Daniele Crosti, Roberto Garzonio, Giorgio Gandaglia, Martina Faticoni, Grant office, Chris Bangma, Maria Jongerden, Derya Tilki, Anssi Auvinen, Teemu Murtola, Tapio Visakorpi, Kirsi Talala, Teuvo Tammela, Aino Siltari, Stephane Lejeune, Laurence Colette, Simona Caputova, Delielena Poli, Sophie Byrne, Luz Fialho, Ashley Rowland, Neo Tapela, Nicola Di Flora, Kathi Apostolidis, Valerie Lemair, Bertrand De Meulder, Charles Auffray, Nesrine Taibi, Ayman Hijazy, Albert Saporta, Kai Sun, Shaun Power, Nazanin Zounemat Kermani, Kees van Bochove, Azadeh Tafreshiha, Chiara Bernini, Denis Horgan, Louise Fullwood, Marc Holtorf, Doron Lancet, Gabi Bernstein, Sheela Tripathee, Manfred Wirth, Michael Froehner, Beate Brenner, Angelika Borkowetz, Christian Thomas, Friedemann Horn, Kristin Reiche, Markus Kreuz, Andreas Josefsson, Delila Gasi Tandefelt, Jonas Hugosson, Jack Schalken, Henkjan Huisman, Thomas Hofmarcher, Peter Lindgren, Emelie Andersson, Adam Fridhammar, Monica Tames Grijalva, Susan Evans-Axelsson, Frank Verholen, Jihong Zong, John-Edward Butler-Ransohoff, Todd Williamson, Reg Waldeck, Amanda Bruno, Ekaterina Nevedomskaya, Samuel Fatoba, Niculae Constantinovici, Carl Steinbeisser, Monika Maass, Patrizia Torremante, Emmanuelle Dochy, Federica Pisa, Marc Dietrich Voss, Kishore Papineni, Jing Wang-silvanto, Robert Snijder, Xuewei Wang, Mark Lambrecht, Russ Wolfinger, Sherinne Eid, Soundarya Palanisamy, Samiul Haque, Laurent Antoni, Angela Servan, Katie Pascoe, Paul Robinson, Joana Lencart, Bertrand Jaton, Heidi Turunen, Olavi Kilkku, Pasi Pohjanjousi, Olli Voima, Liina Nevalaita, Keijo Punakivi, Sarah Seager, Shilpa Ratwani, Katarzyna Grzeslak, James Brash, Elaine Longden-Chapman, Danny Burke, Muriel Licour, Sarah Payne, Alan Yong, Flavia Lujan, Sophia Le Mare, Jan Hendrich, Michael Bussmann, Juckeland, Kotik, Christian Reich
المصدر: European Urology Open Science, Vol 59, Iss , Pp 27-29 (2024)
مصطلحات موضوعية: Cancer survivorship, Prostate cancer, Quality of life, Patient-reported outcome measures, Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Cancer survivorship was recently identified as a prostate cancer (PCa) research priority by PIONEER, a European network of excellence for big data in PCa. Despite being a research priority, cancer survivorship lacks a clear and agreed definition, and there is a distinct paucity of patient-reported outcome (PRO) data available on the subject. Data collection on cancer survivorship depends on the availability and implementation of (validated) routinely collected patient-reported outcome measures (PROMs). There have been recent advances in the availability of such PROMs. For instance, the European Organisation for Research and Treatment of Cancer Quality of Life Group (EORTC QLG) is developing survivorship questionnaires. This provides an excellent first step in improving the data available on cancer survivorship. However, we propose that an agreed, standardised definition of (prostate) cancer survivorship must first be established. Only then can real-world data on survivorship be collected to strengthen our knowledge base. With more men than ever surviving PCa, this type of research is imperative to ensure that the quality of life of these men is considered as much as their quantity of life. Patient summary: As there are more prostate cancer survivors than ever before, research into cancer survivorship is crucial. We highlight the importance of such research and provide recommendations on how to carry it out. The first step should be establishing agreement on a standardised definition of survivorship. From this, patient-reported outcome measures can then be used to collect important survivorship data.
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2666168323023157Test; https://doaj.org/toc/2666-1683Test
-
2دورية أكاديمية
المؤلفون: Antonella Cardone, Nicolas Mottet, Lisa Moris, Michael Lardas, Anna Haire, Francesco Barletta, Simone Scuderi, Eleni Vradi, Giorgio Gandaglia, Steven MacLennan, Bahman Farahmand, Sara J Maclennan, Zsuzsanna Devecseri, Alex Asiimwe, Laurence Collette, Anders Bjartell, James Ndow, James N'Dow, Karin Plass, Maria Ribal, Thomas Van den Broeck, Peter-Paul Willemse, Karl H Pang, Riccardo Campi, Isabella Greco, Mauro Gacci, Sergio Serni, Susan Evans-Axelsson, Ragnar Lonnerbro, Daniele Crosti, Massimiliano Meoni, Roberto Garzonio, Chris Bangma, Monique Roobol, Sebastiaan Remmers, Derya Tilki, Teemu Murtola, Tapio Visakorpi, Kirsi Talala, Teuvo Tammela, Aino Siltari, Stephane Lejeune, Femke van Diggelen, Georgia Taxiarchopoulou, Ketharini Senthilkumar, Stefanie Schütte, Sophie Byrne, Luz Fialho, Paulina Gono, Monica De Vetter, Klevisa Ceke, Bertrand De Meulder, Charles Auffray, Irina-Afrodita Balaur, Nesrine Taibi, Shaun Power, Nazanin Zounemat Kermani, Kees van Bochove, Marinel Cavelaars, Maxim Moinat, Emma Voss, Chiara Bernini, Denis Horgan, Louise Fullwood, Marc Holtorf, Doron Lancet, Gabi Bernstein, Imran Omar, Sara MacLennan, Jemma Healey, Johannes Huber, Manfred Wirth, Michael Froehner, Beate Brenner, Angelika Borkowetz, Christian Thomas, Friedemann Horn, Kristin Reiche, Markus Kreuz, Andreas Josefsson, Delila Gasi Tandefelt, Jonas Hugosson, Jack Schalken, Henkjan Huisman, Thomas Hofmarcher, Emelie Andersson, Adam Fridhammar, Frank Verholen, John-Edward Butler-Ransohoff, Todd Williamson, Kumari Chandrawansa, Dorothy Dlamini, Reg Waldeck, Megan Molnar, Amanda Bruno, Ronald Herrera, Ekaterina Nevedomskaya, Niculae Constantinovici, Carl Steinbeißer, Sini Thomas, Monika Maass, Patrizia Torremante, Marc Dietrich Voss, Guido Cuperus, Chad Dau Kishore, Papineni Jing, Wang-silvanto Steve, Hass Robert, Snijder Verena, Doyé Xuewei, Wang Andy Garnham, Mark Lambrecht, Russ Wolfinger, Stijn Rogiers, Angela Servan, Florence Lefresne, Joaquin Casariego, Mohamed Samir, Joe Lawson, Katie Pascoe, Bertrand Jaton, Daniel Bakkard, Heidi Turunen, Olavi Kilkku, Pasi Pohjanjousi, Olli Voima, Liina Nevalaita, Sonia Araujo, Elaine Longden-Chapman, Gordon McVie, Danny Burke, Paul Agapow, Sahra Derkits, Muriel Licour, Charles McCrea, Sarah Payne, Alan Yong, Flavia Lujan, Billy Franks, Michael Bussmann, Inken Köhle
المصدر: BMJ Open, Vol 11, Iss 2 (2021)
مصطلحات موضوعية: Medicine
الوصف: Introduction As part of the PIONEER (Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe) Consortium, we will explore which diagnostic and prognostic factors (DPFs) are currently being researched to previously defined clinical and patient-reported outcomes for prostate cancer (PCa).Methods and analysis This research project will follow the following four steps: (1) a broad systematic literature review of DPFs for all stages of PCa, covering evidence from 2014 onwards; (2) discussion of systematic review findings by a multidisciplinary expert panel; (3) risk of bias assessment and applicability with Prediction model Risk Of Bias Assessment Tool criteria, Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) and the Quality In Prognosis Studies tool (QUIPS) and (4) additional quantitative assessments if required.Ethics and dissemination We aim to develop an online tool to present the DPFs identified in this research and make them available across all stakeholders. There are no ethical implications.
وصف الملف: electronic resource
-
3
المؤلفون: Heidi Turunen
المساهمون: Department of Architecture, Aalto-yliopisto, Aalto University
مصطلحات موضوعية: architecture, interdisciplinarity, Renewable Energy, Sustainability and the Environment, materials research, materials life cycle, Architecture, Building and Construction, materials development, Civil and Structural Engineering
الوصف: Funding Information: This work was supported by Tekes, The Finnish Funding Agency for Technology and Innovation (currently Business Finland), and the Finnish Cultural Foundation: Kalle ja Dagmar Välimaan Rahasto and Suomen Hypoteekkiyhdistyksen Rahasto. Publisher Copyright: © 2022, Kauno Technologijos Universitetas. All rights reserved. The materials life cycle consists of several phases. If application areas are targeted for architecture, comprehending the demands of the end-use phase might not be clear at the research and development phase, leading to an entity appearing fragmented. The aim of this study is to help bring order to the material research or development phases. The objective is to generate a review tool, which helps to observe different areas where architecture operates, and contemplate simultaneously the aspects during the different phases of the material development. The review tool of the material life cycle consists of tracking the raw materials until the re-used raw material, resulting in eight different stages of the material life cycle. In addition, each of the eight stages of the material life cycle is possible to observe with the five different viewpoints, which are present in architecture. These eight material life cycle stages and five aspects have been formulated as a chart. The chart consists of 40 different approaches facilitating discussion between different operators during the different phases of the material development. The chart might help set goals, frame areas, and improve comprehension of the research and development processes of the materials, especially when interdisciplinarity is involved in the research process.
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f0de805a99fd55d2bef4ff136f582cTest
https://aaltodoc.aalto.fi/handle/123456789/117828Test -
4دورية أكاديمية
المؤلفون: Heidi Turunen (11221039), Stephan M Jakob (11221042), Esko Ruokonen (55521), Kirsi-Maija Kaukonen (8161092), Toni Sarapohja (11221045), Marjo Apajasalo (11221048), Jukka Takala (24249)
مصطلحات موضوعية: Medicine, Pharmacology, Ecology, Sociology, Science Policy, Biological Sciences not elsewhere classified, Intensive Care Unit, Intensive Care Unit Stay, Dexmedetomidine, Intensive Care Unit Discharge, Therapeutic Intervention Scoring System
الوصف: Copy of the Therapeutic Intervention Scoring System-28 (TISS-28) scoring tool.
-
5دورية أكاديمية
المؤلفون: Heidi Turunen (11221039), Stephan M Jakob (11221042), Esko Ruokonen (55521), Kirsi-Maija Kaukonen (8161092), Toni Sarapohja (11221045), Marjo Apajasalo (11221048), Jukka Takala (24249)
مصطلحات موضوعية: Medicine, Pharmacology, Ecology, Sociology, Science Policy, Biological Sciences not elsewhere classified, Intensive Care Unit, Intensive Care Unit Stay, Dexmedetomidine, Intensive Care Unit Discharge, Therapeutic Intervention Scoring System
الوصف: List of the ethics committees that approved the clinical trial protocols.
-
6دورية أكاديمية
المؤلفون: Heidi Turunen (11221039), Stephan M Jakob (11221042), Esko Ruokonen (55521), Kirsi-Maija Kaukonen (8161092), Toni Sarapohja (11221045), Marjo Apajasalo (11221048), Jukka Takala (24249)
مصطلحات موضوعية: Medicine, Pharmacology, Ecology, Sociology, Science Policy, Biological Sciences not elsewhere classified, Intensive Care Unit, Intensive Care Unit Stay, Dexmedetomidine, Intensive Care Unit Discharge, Therapeutic Intervention Scoring System
الوصف: Combined bootstrapping analysis of the total intensive care unit (ICU) costs and the key underlying resource use parameter, time to extubation, in pooled population.
-
7دورية أكاديمية
المؤلفون: Heidi Turunen (11221039), Stephan M Jakob (11221042), Esko Ruokonen (55521), Kirsi-Maija Kaukonen (8161092), Toni Sarapohja (11221045), Marjo Apajasalo (11221048), Jukka Takala (24249)
مصطلحات موضوعية: Medicine, Pharmacology, Ecology, Sociology, Science Policy, Biological Sciences not elsewhere classified, Intensive Care Unit, Intensive Care Unit Stay, Dexmedetomidine, Intensive Care Unit Discharge, Therapeutic Intervention Scoring System
الوصف: Duration of the different intensive care unit (ICU) periods by mechanical ventilation use, and the duration of post-ICU ward stay.
-
8دورية أكاديمية
المؤلفون: Heidi Turunen (11221039), Stephan M Jakob (11221042), Esko Ruokonen (55521), Kirsi-Maija Kaukonen (8161092), Toni Sarapohja (11221045), Marjo Apajasalo (11221048), Jukka Takala (24249)
مصطلحات موضوعية: Medicine, Pharmacology, Ecology, Sociology, Science Policy, Biological Sciences not elsewhere classified, Intensive Care Unit, Intensive Care Unit Stay, Dexmedetomidine, Intensive Care Unit Discharge, Therapeutic Intervention Scoring System
الوصف: Differences in study population and imputation approach in the current economic vs. the original clinical analysis with ITT data.
-
9دورية أكاديمية
المؤلفون: Heidi Turunen (11221039), Stephan M Jakob (11221042), Esko Ruokonen (55521), Kirsi-Maija Kaukonen (8161092), Toni Sarapohja (11221045), Marjo Apajasalo (11221048), Jukka Takala (24249)
مصطلحات موضوعية: Medicine, Pharmacology, Ecology, Sociology, Science Policy, Biological Sciences not elsewhere classified, Intensive Care Unit, Intensive Care Unit Stay, Dexmedetomidine, Intensive Care Unit Discharge, Therapeutic Intervention Scoring System
الوصف: Acquisition costs of the study sedatives in pooled population and the MIDEX and PRODEX trials.
-
10دورية أكاديمية
المؤلفون: Heidi Turunen (11221039), Stephan M Jakob (11221042), Esko Ruokonen (55521), Kirsi-Maija Kaukonen (8161092), Toni Sarapohja (11221045), Marjo Apajasalo (11221048), Jukka Takala (24249)
مصطلحات موضوعية: Medicine, Pharmacology, Ecology, Sociology, Science Policy, Biological Sciences not elsewhere classified, Intensive Care Unit, Intensive Care Unit Stay, Dexmedetomidine, Intensive Care Unit Discharge, Therapeutic Intervention Scoring System
الوصف: Total intensive care unit (ICU) costs in patients with observed data available from all three time points, without any censoring or data imputations, in the pooled data analysis (S6). Table S5. Total intensive care unit (ICU) costs with dexmedetomidine and current standard care sedatives in the 18 centers whose routine daily ICU cost information the unit cost assumptions in this work were based on (S7).
النص الكامل